封面
市場調查報告書
商品編碼
1701975

乳房病變定位方法市場報告(按類型、用途、最終用戶和地區)2025-2033

Breast Lesion Localization Methods Market Report by Type, Usage, End User, and Region 2025-2033

出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球乳房病變定位方法市場規模達 13.22 億美元。展望未來, IMARC Group預計到 2033 年市場規模將達到 27.91 億美元,2025-2033 年期間的成長率 (CAGR) 為 8.7%。

乳房病變定位方法是指採用各種程序來檢測因疾病或損傷引起的乳房組織異常變化(也稱為乳房病變)。一些常用的方法包括導絲定位、碳標記、放射導引隱匿性病灶定位 (ROLL)、放射性粒子定位 (RSL)、磁性粒子定位 (Magseed) 和術中超音波 (IOUS)。這些技術可幫助醫生和醫療保健專業人員做出明智的決定並確定患者的理想治療或手術。隨著外科、影像和生物醫學技術的進步,乳房病變定位方法得到了顯著發展,這正在推動醫療保健領域對其的需求。

乳房病變定位方法市場趨勢:

由於生活方式的改變和不健康的飲食導致乳癌病例大幅增加是推動市場成長的主要因素。除此之外,需要進行乳房腫瘤切除術和手術活體組織切片的患者數量不斷增加,這也增加了對乳房病變定位方法的需求,以確保準確切除目標病變。此外,各國的管理機構正採取積極舉措,宣傳早期發現乳癌的好處。例如,澳洲政府啟動了「澳洲乳癌篩檢」項目,這是一項全國性的乳癌篩檢計劃,每兩年為50至74歲的女性提供一次免費的乳房X光檢查。再加上政府和私人對乳癌診斷、活體組織切片和其他相關醫療程序的報銷政策不斷增加,以及領先企業推出創新乳房病變定位設備,共同推動了市場的成長。此外,對研發 (R&D) 活動的大量投資為市場參與者提供了豐厚的機會。其他因素,包括接受隆乳等整容手術的人數不斷增加、醫療基礎設施的改善、技術進步以及消費者醫療保健支出的增加,也創造了積極的市場前景。

本報告回答的關鍵問題

  • 2024年全球乳房病變定位方法市場規模? 2025-2033年全球乳房病變定位方法市場的預期成長率是多少?
  • 推動全球乳房病變定位方法市場發展的關鍵因素有哪些?
  • COVID-19 對全球乳房病變定位方法市場有何影響?
  • 全球乳房病變定位方法市場依類型分為哪些類型?
  • 根據用途,全球乳房病變定位方法市場如何分佈?
  • 根據最終用戶,全球乳房病變定位方法市場如何分佈?
  • 全球乳房病變定位方法市場的主要區域有哪些?
  • 全球乳房病變定位方法市場的主要參與者/公司有哪些?

目錄

第1章:前言

第2章:範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章:執行摘要

第4章:簡介

  • 概述
  • 主要行業趨勢

第5章:全球乳房病變定位方法市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章:市場細分:依類型

  • 線路定位
  • 放射性同位素定位
  • 磁示踪劑定位
  • 其他

第7章:市場區隔:依用途

  • 腫瘤識別
  • 前哨淋巴結識別
    • 關鍵部分
      • 乳房腫瘤切除手術
      • 乳房切除手術

第8章:市場區隔:按最終用戶

  • 醫院
  • 診斷中心
  • 腫瘤診所
  • 門診手術中心

第9章:市場細分:依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔:依國家

第10章:SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章:價值鏈分析

第 12 章:波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章:價格分析

第 14 章:競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Argon Medical Devices Inc.
    • Becton Dickinson and Company
    • Cook Group Incorporated
    • CP Medical Inc. (Theragenics Corporation)
    • Endomagnetics Ltd.
    • Hologic Inc.
    • IsoAid LLC
    • IZI Medical Products (Landauer Inc)
    • Laurane Medical LLC
    • Leica Biosystems Nussloch GmbH (Danaher Corporation)
    • Merit Medical Systems Inc.
    • Sterylab Srl
Product Code: SR112025A4890

The global breast lesion localization methods market size reached USD 1,322 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 2,791 Million by 2033, exhibiting a growth rate (CAGR) of 8.7% during 2025-2033.

Breast lesion localization methods refer to various procedures employed to detect abnormal changes in the breast tissue, also called a breast lesion, caused due to a disease or injury. Some commonly used methods include wire localization, carbon marking, radio-guided occult lesion localization (ROLL), radioactive seed localization (RSL), magnetic seed localization (Magseed), and intraoperative ultrasound (IOUS). These techniques assist doctors and healthcare professionals in making informed decisions and determining the ideal treatment or surgery for the patient. With advancements in surgical, imaging and biomedical technology, breast lesion localization methods have significantly evolved, which is presently driving their demand in the healthcare sector.

Breast Lesion Localization Methods Market Trends:

A significant increase in breast cancer cases due to changing lifestyles, and unhealthy diets represents the primary factor driving the market growth. Besides this, the growing number of patients requiring lumpectomy and surgical biopsy procedures is augmenting the demand for breast lesion localization methods to ensure accurate removal of the target lesion. Additionally, the governing agencies of various countries are taking favorable initiatives to spread awareness regarding the benefits of early detection of breast cancer. For instance, the Government of Australia launched BreastScreen Australia, a national breast cancer screening program that provides a free mammogram to women aged 50-74 every two years. This, in confluence with the increasing number of government and private reimbursement policies for breast cancer diagnosis, biopsy and other related medical procedures and the launch of innovative breast lesion localization devices by leading players, is catalyzing the market growth. Furthermore, heavy investments in research and development (R&D) activities are offering lucrative opportunities to the market players. Other factors, including the rising number of individuals undergoing cosmetic surgeries like breast enhancement, improving healthcare infrastructure, technological advancements, and increasing consumer healthcare spending, are also creating a positive market outlook.

Key Market Segmentation:

Breakup by Type:

  • Wire Localization
  • Radioisotope Localization
  • Magnetic Tracers Localization
  • Others

Breakup by Usage:

  • Tumor Identification
  • Sentinel Lymph Node Identification
  • Lumpectomy
  • Mastectomy

Breakup by End User:

  • Hospitals
  • Diagnostic Centres
  • Oncology Clinics
  • Ambulatory Surgical Centers

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Argon Medical Devices Inc., Becton Dickinson and Company, Cook Group Incorporated, CP Medical Inc. (Theragenics Corporation), Endomagnetics Ltd., Hologic Inc., IsoAid LLC, IZI Medical Products (Landauer Inc), Laurane Medical LLC, Leica Biosystems Nussloch GmbH (Danaher Corporation), Merit Medical Systems Inc. and Sterylab S.r.l.

Key Questions Answered in This Report

  • 1.What was the size of the global breast lesion localization methods market in 2024?
  • 2.What is the expected growth rate of the global breast lesion localization methods market during 2025-2033?
  • 3.What are the key factors driving the global breast lesion localization methods market?
  • 4.What has been the impact of COVID-19 on the global breast lesion localization methods market?
  • 5.What is the breakup of the global breast lesion localization methods market based on type?
  • 6.What is the breakup of the global breast lesion localization methods market based on the usage?
  • 7.What is the breakup of the global breast lesion localization methods market based on the end user?
  • 8.What are the key regions in the global breast lesion localization methods market?
  • 9.Who are the key players/companies in the global breast lesion localization methods market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Breast Lesion Localization Methods Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Wire Localization
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Radioisotope Localization
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Magnetic Tracers Localization
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Usage

  • 7.1 Tumor Identification
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Sentinel Lymph Node Identification
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Lumpectomy
      • 7.2.2.2 Mastectomy
    • 7.2.3 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostic Centres
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Oncology Clinics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Ambulatory Surgical Centers
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Argon Medical Devices Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Cook Group Incorporated
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 CP Medical Inc. (Theragenics Corporation)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Endomagnetics Ltd.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Hologic Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 IsoAid LLC
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 IZI Medical Products (Landauer Inc)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Laurane Medical LLC
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Leica Biosystems Nussloch GmbH (Danaher Corporation)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Merit Medical Systems Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Sterylab S.r.l
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Breast Lesion Localization Methods Market: Major Drivers and Challenges
  • Figure 2: Global: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Breast Lesion Localization Methods Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Breast Lesion Localization Methods Market: Breakup by Usage (in %), 2024
  • Figure 6: Global: Breast Lesion Localization Methods Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Breast Lesion Localization Methods Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Breast Lesion Localization Methods (Wire Localization) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Breast Lesion Localization Methods (Wire Localization) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Breast Lesion Localization Methods (Radioisotope Localization) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Breast Lesion Localization Methods (Radioisotope Localization) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Breast Lesion Localization Methods (Magnetic Tracers Localization) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Breast Lesion Localization Methods (Magnetic Tracers Localization) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Breast Lesion Localization Methods (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Breast Lesion Localization Methods (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Breast Lesion Localization Methods (Tumor Identification) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Breast Lesion Localization Methods (Tumor Identification) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Breast Lesion Localization Methods (Sentinel Lymph Node Identification) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Breast Lesion Localization Methods (Sentinel Lymph Node Identification) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Breast Lesion Localization Methods (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Breast Lesion Localization Methods (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Breast Lesion Localization Methods (Diagnostic Centres) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Breast Lesion Localization Methods (Diagnostic Centres) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Breast Lesion Localization Methods (Oncology Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Breast Lesion Localization Methods (Oncology Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Breast Lesion Localization Methods (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Breast Lesion Localization Methods (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: North America: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: North America: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: United States: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: United States: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Canada: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Canada: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Asia-Pacific: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Asia-Pacific: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: China: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: China: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Japan: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Japan: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: India: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: India: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: South Korea: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: South Korea: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Australia: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Australia: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Indonesia: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Indonesia: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Others: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Others: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Europe: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Europe: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Germany: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Germany: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: France: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: France: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: United Kingdom: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: United Kingdom: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Italy: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Italy: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Spain: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Spain: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Russia: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Russia: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Others: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Others: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Latin America: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Latin America: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Brazil: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Brazil: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Mexico: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Mexico: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Middle East and Africa: Breast Lesion Localization Methods Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Middle East and Africa: Breast Lesion Localization Methods Market: Breakup by Country (in %), 2024
  • Figure 76: Middle East and Africa: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Global: Breast Lesion Localization Methods Industry: SWOT Analysis
  • Figure 78: Global: Breast Lesion Localization Methods Industry: Value Chain Analysis
  • Figure 79: Global: Breast Lesion Localization Methods Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Breast Lesion Localization Methods Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Breast Lesion Localization Methods Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Breast Lesion Localization Methods Market Forecast: Breakup by Usage (in Million USD), 2025-2033
  • Table 4: Global: Breast Lesion Localization Methods Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Breast Lesion Localization Methods Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Breast Lesion Localization Methods Market: Competitive Structure
  • Table 7: Global: Breast Lesion Localization Methods Market: Key Players